In 2018, the Hamburg life science company is presenting its highly prestigious research prize for the 23rd time. The ind...
Swiss drug major Roche Group has appointed James Sabry as Global Head of Partnering, a role that combines the partnering...
A study from a Massachusetts General Hospital (MGH) research team reports that after three years of receiving two a...
Researchers funded by the National Institute on Aging (NIA), a part of the National Institutes of Health have made a dis...
Beckman Coulter Diagnostics, a global leader in the clinical diagnostics industry, has embarked on a strategic collabora...
Singapore- PolarityTE announced that Paul Mann of Highbridge Capital Management is the new Chief Financial Officer of th...
The American Heart Association (AHA) and the American Diabetes Association (ADA) has announced the start of a new multi-...
Novartis announced today that the US Food and Drug Administration (FDA) approved the inclusion of new evidence that Cose...
Seema Kumar, Vice President of Innovation, Global Health and Science Policy Communication for Johnson & Johnson was ...
MedUni Vienna has developed a method that can be used to identify individual rhinovirus strains ("cold viruses") as a ca...
Global pharmaceutical company Mylan has announced the US launch of Bivalirudin for Injection, 250 mg singl...
An international team of researchers has developed a new minimally invasive medical device called Therepi that can be pl...
Life Sciences informatics company Benchling said that it closed a $14.5 million Series B round of venture capital. Bench...
The 2018 BIO International Convention (BIO 2018) recently wrapped up four days of programming under the theme ...
TiGenix, an advanced biopharmaceutical company focused on exploiting the anti-inflammatory properties of allogeneic, or ...
Over the past several years, HIV researchers have identified many broadly neutralizing antibodies that can protect human...
Vergent Bioscience, a cancer-focused biotechnology company has announced that it raised $8.7 million in a Series A finan...
Singapore- Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins, announced that Ha...
